| Today, Wed, Feb 10, 2010 | | | Targeted Genetics completes $7M Genzyme deal at bizjournals.com (Wed 3:05AM)
| | Tue, Feb 9, 2010 | | | Weekly Street Sentiment: Sell-Side Still Searching for Direction at Seeking Alpha (Tue 8:52PM)
| | | PREVIEW-Genzyme competition may get clearer at conference at Reuters (Tue 6:37AM)
| | | GSK: Rare Diseases Now Big Business at The Wall Street Journal Online (Tue 2:56AM)
| | Sat, Feb 6, 2010 | | | 5 Beaten Down Stocks Ready For Reversal at Investopedia (Sat, Feb 6)
| | Fri, Feb 5, 2010 | | | Biotech Stock Mailbag: Soligenix at TheStreet.com (Fri, Feb 5)
| | | My Favorite Investor at Motley Fool (Fri, Feb 5)
| | Thu, Feb 4, 2010 | | | Biotech Stocks: Pfizer leads drug stocks south at MarketWatch (Thu, Feb 4)
| | | Pfizer's Hedge Pays Off at Motley Fool (Thu, Feb 4)
| | | Genzyme names global manufacturing president AP (Thu, Feb 4)
| | | UPDATE - Genzyme names ex-Lilly exec to head manufacturing at Reuters (Thu, Feb 4)
| | | Ahead of the Bell: Genzyme upgraded to 'Buy' AP (Thu, Feb 4)
| | | Scott Canute Joins Genzyme to Head Manufacturing and Corporate Operations Business Wire (Thu, Feb 4)
| | | Genzyme upgraded by UBS Briefing.com (Thu, Feb 4)
| | Wed, Feb 3, 2010 | | | [video] Go High-Quality with JNJ: China Watch at TheStreet.com (Wed, Feb 3)
| | | Latin America Led World Stock Funds Lower In January Investor's Business Daily (Wed, Feb 3)
| | | Another Setback for Protalix at Seeking Alpha (Wed, Feb 3)
| | | Pfizer Earnings By the Numbers at CNBC (Wed, Feb 3)
| | Tue, Feb 2, 2010 | | | Bargains to be found in health-care stocks Fortune (Tue, Feb 2)
| | | Cell Therapeutics' Upcoming FDA Worries at TheStreet.com (Tue, Feb 2)
| | Older Headlines | |
| |
|